Description

Zion Labs T-5 (ECA Stack)

Brand: Zion Labs
Category: Thermogenic · High-stim ECA (Ephedrine + Caffeine + Aspirin)
Content: 90 capsules
Per Capsule (Label): Ephedrine 30 mg · Caffeine 250 mg · Aspirin 150 mg
Manufactured in: Cyprus
Price: €22
Research Notice: For laboratory and analytical use only. Not for human or veterinary consumption.

🧪 Product Overview

T-5 by Zion Labs is a classical ECA stack combining
ephedrine, caffeine, and aspirin into a single high-stimulus capsule aimed at
research on:

• thermogenesis and metabolic stimulation
• adrenergic signaling and norepinephrine-driven pathways
• energy, focus, and pre-exercise arousal
• body-mass and calorie-restriction models
• stimulant synergy (ephedrine + caffeine)

ECA protocols are extensively referenced in older metabolic and obesity studies, making T-5 a structured stimulant model for comparative research.

✅ Key Research Highlights

Ephedrine (30 mg):
Indirect sympathomimetic that increases norepinephrine release and stimulates β-adrenergic receptors → promotes lipolysis, thermogenesis, and increased energy expenditure.
Studies consistently show enhanced thermogenesis when paired with caffeine.

Caffeine (250 mg):
Adenosine A1/A2A antagonist → heightened CNS arousal, reduced perceived effort, improved alertness, and potential metabolic increases.
Commonly researched in performance and weight-management contexts.

Aspirin (150 mg):
Included historically in ECA protocols; proposed to attenuate prostaglandin-mediated feedback. Evidence suggests limited enhancement beyond EC alone but remains part of traditional triads.

🧬 Mechanism of Action (Simplified)

• Ephedrine: Increases synaptic NE → β-adrenergic activation → lipolysis + thermogenic output.
• Caffeine: Blocks adenosine receptors → boosts alertness, metabolic activity, and enhances ephedrine response.
• Aspirin: Historically added to prolong thermogenic signaling (evidence variable).

📊 Technical Specification Table

📚 Research Background

• ECA literature: Studies indicate increased metabolic rate and short-term body-mass reduction via β-adrenergic stimulation and caffeine synergy.
• Caffeine potentiation: Caffeine enhances ephedrine’s thermogenic effect in multiple controlled papers.
• Safety drives regulation: Cardiovascular and CNS risks prompted global regulatory tightening.

⚠️ Potential Side Effects (Class-Based Literature)

• Elevated blood pressure, tachycardia, palpitations
• Insomnia, anxiety, tremors, agitation
• Headache, nausea, GI discomfort
• Rare severe events: arrhythmia, stroke, myocardial infarction
• Risk increases when combined with other stimulants or MAO inhibitors

🧯 Compliance & Doping Status

Sport:
Ephedrine is prohibited in-competition above 10 µg/mL urine under WADA rules.
Athletes should avoid use and consult federation guidelines.

Regulation:
Ephedrine-containing dietary supplements are illegal in the U.S. and restricted in many jurisdictions. Importation or sale may be blocked by authorities.

Research-only:
Not a supplement or medication. No human consumption implied. Supplied for analytical, forensic, and laboratory work only.

📌 Important Notice

For research use only. Not a dietary supplement, not a medicine, and not for performance enhancement.
Users must follow local laws, laboratory safety policies, and anti-doping rules.